Consensus Statement | Published:

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary

Eyevolume 32pages11681173 (2018) | Download Citation

Subjects

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Imran H. Yusuf, Barny Foot, James Galloway, Michael R. Ardern-Jones, Sarah-Lucie Watson, Cathy Yelf, Michael A. Burdon, Paul N. Bishop, Andrew J. Lotery. Royal College of Ophthalmologists Guideline Development Group - Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening. https://www.rcophth.ac.uk/standards-publications-research/clinical-guidelines/ Accessed 3 March 2018.

  2. 2.

    Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye. 2017;31:828–45.

  3. 3.

    Alarcon GS, McGwin G, Bertoli AM, et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168–72.

  4. 4.

    Yates M, Malaiya R, Stack J, Galloway JB. Hydroxychloroquine use: the potential impact of new ocular screening guidelines. Eye. 2018;32:161–2.

  5. 5.

    Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110:1321–6.

  6. 6.

    Richard Smith, Brian Bourke, Stephen Jones, Arul k Rajammal, Alan Silman. Hydroxychloroquine and Ocular Toxicity Recommendations on Screening. The Royal College of Ophthalmologists 2009.

  7. 7.

    Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132:1453–60.

  8. 8.

    Latasiewicz M, Gourier H, Yusuf IH, et al. Hydroxychloroquine retinopathy: an emerging problem. Eye. 2017;31:972–6.

  9. 9.

    Imran H. Yusuf, Cathy Yelf. Eye screening for patients taking hydroxychloroquine (Plaquenil®): Macular Society. https://www.macularsociety.org/sites/default/files/resource/Hydroxychloroquine%20-%20access.pdf Accessed 1 March 2018.

Download references

Acknowledgements

We thank our expert reviewers, Dr Ron Melles and Mr Alastair Denniston, college members who provided feedback on these draft guidelines and Iris Gordon from the Cochrane Eyes and Vision Group for assistance in searching the evidence basis.

Author contributions

The Multidisciplinary guideline development group was chaired by AJL. IHY was involved in grading the evidence, writing the first draft of the guideline. BF represented The Royal College of Ophthalmologists and supported the guidance development process. PNB, MAB and S-LW provided ophthalmic specialist clinical input. JG represented the British Society for Rheumatology and provided rheumatological specialist clinical input. MRA-J represented the British Association of Dermatologists and provided dermatological specialist clinical input. CY contributed as a Patient and Carer representation.

Author information

Affiliations

  1. Oxford Eye Hospital, West Wing, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK

    • Imran H. Yusuf
  2. The Royal College of Ophthalmologists, 18 Stephenson Way, Kings Cross, London, NW1 2HD, UK

    • Barny Foot
  3. Department of Rheumatology, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK

    • James Galloway
  4. Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Tremona Road, Southampton, Hampshire, SO16 6YD, UK

    • Michael R. Ardern-Jones
  5. Royal Berkshire Hospital, London Road, Reading, Berkshire, RG1 5AN, UK

    • Sarah-Lucie Watson
  6. The Macular Society, Crown Chambers, South St, Andover, Hampshire, SP10 2BN, UK

    • Cathy Yelf
  7. Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK

    • Michael A. Burdon
  8. Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, M13 9WL & School of Biological Sciences, University of Manchester, Manchester, M13 9PL, UK

    • Paul N. Bishop
  9. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK

    • Andrew J. Lotery

Authors

  1. Search for Imran H. Yusuf in:

  2. Search for Barny Foot in:

  3. Search for James Galloway in:

  4. Search for Michael R. Ardern-Jones in:

  5. Search for Sarah-Lucie Watson in:

  6. Search for Cathy Yelf in:

  7. Search for Michael A. Burdon in:

  8. Search for Paul N. Bishop in:

  9. Search for Andrew J. Lotery in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to Andrew J. Lotery.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/s41433-018-0136-x